化学
广告
体外
吸入
嘌呤
PI3K/AKT/mTOR通路
慢性阻塞性肺病
药品
药理学
药物发现
嘌呤类似物
哮喘
嘌呤代谢
生物化学
酶
免疫学
信号转导
麻醉
内科学
医学
作者
Roberta Mazzucato,Marinella Roberti,Anna Maria Capelli,Fabio Rancati,Matteo Biagetti,Claudio Fiorelli,P. Bruno,Paolo Ronchi,Serena Bertolini,Mauro Corsi,Daniele Pala
标识
DOI:10.1016/j.ejmech.2023.115331
摘要
PI3Kδ is a lipid kinase which plays a key role in airway inflammatory conditions. Accordingly, the inhibition of PI3Kδ can be considered a valuable strategy for the treatment of chronic respiratory diseases such as Asthma and Chronic obstructive pulmonary disease (COPD). In this work, we describe our efforts to identify new PI3Kδ inhibitors following an "inhalation by design" strategy. Starting from the identification of a purine scaffold, we carried out a preliminary SAR expansion which led to the identification of a new hit characterized by a high enzymatic potency and moderate PI3Kδ selectivity. A subsequent optimization led to novel purine based derivatives with favorable in vitro ADME profiles, which might represent promising starting points for future development of new inhaled drug candidates.
科研通智能强力驱动
Strongly Powered by AbleSci AI